Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News NeutriSci International Inc NRXCF


Primary Symbol: V.NU.H

Consumer Defensive Household & Personal Products Cannabis
NeutriSci International Inc. (NeutriSci) is a Canada-based company, which specializes in the production, and formulation of nutraceutical products within the business-to-business (B2B) industry. The Company is focused on the market development for its nutraceutical products. Its products utilize patented form of Pterostilbene called pTeroPure. pTeroPure Pterostilbene is a form of all-trans... see more

Recent & Breaking News (TSXV:NU.H)

Canadian Investment Regulatory Organization Trading Halt - NU.H

Canada NewsWire May 8, 2024

NEUTRISCI SHIPS ORDER TO TABLETZ DISTRIBUTION PARTNER

Canada NewsWire June 7, 2022

NEUTRISCI PROVIDES UPDATE AND PARTNER PROGRESS

PR Newswire February 3, 2022

NEUTRISCI ANNOUNCES VOLUNTARY DELISTING FROM OTCQB

PR Newswire January 26, 2022

NEUTRISCI SHIPS TABLETZ ORDER TO JAPAN

PR Newswire January 18, 2022

NEUTRISCI SIGNS EXCLUSIVE 5-YEAR DISTRIBUTION AGREEMENT FOR EUROPE AND RECEIVES INITIAL ORDER

PR Newswire January 4, 2022

NEUTRISCI UPDATES MANAGEMENT DISCUSSION AND ANALYSIS'

PR Newswire December 17, 2021

NeutriSci Announces Successful Completion of R&D in Preparation for Launch of Its Functional Mushroom Product Line

Accesswire November 30, 2021

NeutriSci Provides Production Update and Partner Progress

PR Newswire October 12, 2021

NeutriSci Receives Additional Purchase Order and Deposit from Tabletz Distribution Partner

Accesswire September 22, 2021

NeutriSci Arranges Strategic Financing with Tabletz and Exercise of Warrants

Accesswire September 10, 2021

Neutrisci Provides Update on Tabletz Developments

Accesswire August 12, 2021

Neutrisci Provides Update on Tabletz and Previously Announced Project Development

Accesswire July 7, 2021

NeutriSci Provides Update On Biople Product Launch In Japan

Accesswire June 23, 2021

Neutrisci Ships Tabletz Rush Order to #1 CBD Retailer in Japan

Accesswire June 9, 2021

NeutriSci Completes R&D and Expands Product Selection to Include Beverages

Accesswire May 27, 2021

NeutriSci and Pacwest Announce Technology and IP Arrangement for R&D Product Development

Accesswire May 25, 2021

Neutrisci Announces Successful Completion of Phase 1 R&D Development of a Cannabinol Product

Accesswire May 10, 2021

Neutrisci Receives Additional Order for Japanese Market

Accesswire May 3, 2021

Neutrisci Announces New State-Of-The-Art Production and Research Facility in Las Vegas, Nevada, USA

Accesswire March 18, 2021